» Articles » PMID: 16760685

Hypertension in Older People: Part 1

Overview
Date 2006 Jun 9
PMID 16760685
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Once considered part of the normal aging process, the development of isolated systolic hypertension represents a late manifestation of increased arterial stiffness in older people. Furthermore, isolated systolic hypertension is the single most frequent subtype of hypertension in the US adult population. Indeed, central arterial stiffness rather than peripheral vascular resistance becomes the dominant hemodynamic factor in both normotensive and hypertensive individuals after the age of 50-60 years. Stiffening disease, an age-related degeneration of the elastic elements of the thoracic aorta, is associated with a widening of brachial pulse pressure. Brachial pulse pressure predicts future cardiovascular disease events. However, pressure wave amplification produces higher brachial than aortic pressures and, therefore, central rather than peripheral blood pressure indices are more reliable measures of cardiovascular risk. Stiffening disease of aging is accompanied by early wave reflection, which results in a significant augmentation of central systolic pressure in late systole and further adds to increased cardiac afterload--so-called ventricular-vascular uncoupling. Diabetes, impaired renal function, and untreated or poorly treated hypertension may lead to premature arterial stiffening; its consequences are stiffening and hypertrophy of the left ventricle and predisposition to coronary heart disease, heart failure, stroke, vascular dementia, and chronic kidney disease.

Citing Articles

Effects of physical activity on blood pressure and mortality among aged hypertensive patients: A cross-sectional study.

Zhang Z, Xu C, Yu W, Du C, Tang L, Liu X Medicine (Baltimore). 2024; 103(44):e40413.

PMID: 39496004 PMC: 11537630. DOI: 10.1097/MD.0000000000040413.


Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section....

Simonenko M, Hansen D, Niebauer J, Volterrani M, Adamopoulos S, Amarelli C Transpl Int. 2024; 37:13191.

PMID: 39015154 PMC: 11250379. DOI: 10.3389/ti.2024.13191.


The connection between hypertension and diabetes and their role in heart and kidney disease development.

Hezam A, Shaghdar H, Chen L J Res Med Sci. 2024; 29:22.

PMID: 38855561 PMC: 11162087. DOI: 10.4103/jrms.jrms_470_23.


Pulse pressure modifies the association between diastolic blood pressure and decrease in kidney function: the Japan Specific Health Checkups Study.

Tamaki H, Eriguchi M, Yoshida H, Uemura T, Tasaki H, Nishimoto M Clin Kidney J. 2024; 17(6):sfae152.

PMID: 38846104 PMC: 11153873. DOI: 10.1093/ckj/sfae152.


Pulsatility analysis of the circle of Willis.

Voss H, Razlighi Q Aging Brain. 2024; 5:100111.

PMID: 38495808 PMC: 10940807. DOI: 10.1016/j.nbas.2024.100111.


References
1.
Franklin S, Jacobs M, Wong N, LItalien G, Lapuerta P . Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001; 37(3):869-74. DOI: 10.1161/01.hyp.37.3.869. View

2.
Kass D . Ventricular arterial stiffening: integrating the pathophysiology. Hypertension. 2005; 46(1):185-93. DOI: 10.1161/01.HYP.0000168053.34306.d4. View

3.
Franklin S, Gustin 4th W, Wong N, Larson M, Weber M, Kannel W . Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997; 96(1):308-15. DOI: 10.1161/01.cir.96.1.308. View

4.
Staessen J, Fagard R, Thijs L, Celis H, Birkenhager W, Bulpitt C . Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med. 1998; 158(15):1681-91. DOI: 10.1001/archinte.158.15.1681. View

5.
. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288(23):2981-97. DOI: 10.1001/jama.288.23.2981. View